Delivery Order SPE2DB22D1017-SPE2DB25FG6EF
Award Date 6/30/25
Potential Completion Date 7/1/25
Potential Value $2.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Budesonide-Formoterol 80-4.5 10.2GM, a pharmaceutical product, with a total ceiling value of $1,245.92. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Budesonide-Formoterol 80-4.5 10.2GM medication. The contract has a firm fixed price structure and a not-to-exceed ceiling value of $2,118.68. The contract was awarded as a Delivery Order with an ultimate completion date of September 30, 2024. Amerisourcebergen, through its Corporate Office division, will supply this critical...
- This federal contract award, valued at $14,295.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of Budesonide-Formoterol 80-4.5 10.2GM, a pharmaceutical product, with a performance period extending through May 8, 2025. The contract is a firm fixed-price, non-set-aside arrangement, indicating open competition. Amerisourcebergen Drug Corp...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of budesonide-formoterol 160-4.5 10.2GM pharmaceutical products, with a ceiling value of $2,122.18 and a period of performance through July 11, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,760.00, is a delivery order for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product. The contract has an ultimate completion date of March 10, 2025 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award, valued at $1,372.04, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product, with a completion date of February 20, 2025. The contract is a Delivery Order under a Firm Fixed Price structure, and there was no set-aside designation used. AmerisourceBergen holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,382.52 delivery order contract is for the supply of Budesonide-Formoterol 80-4.5 10.2GM, a pharmaceutical product, with a period of performance through January 16, 2025. The contract is a firm fixed-price, delivery order type with no set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Budesonide-Formoterol 80-4.5 10.2GM, a pharmaceutical product. The Firm Fixed Price delivery order contract, valued at $1,047.99, has a period of performance through September 4, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product, with a ceiling value of $2,689.67 and an ultimate completion date of June 18, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and does not have a set-aside designation. Amerisourcebergen Drug...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,310.40 firm fixed-price delivery order contract is for the supply of the pharmaceutical product Budesonide-Formoterol 160-4.5 10.2GM. The contract has an ultimate completion date of January 6, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...